Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ultra Low Dose CT and Use of Iomeron 400 in PCD-CT

NCT06360627 is registered in ClinicalTrials.gov with University of Zurich as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06360627 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ultra Low Dose CT and Use of Iomeron 400 in PCD-CT
Lead sponsor
University of Zurich
Phase
Not applicable
Overall status
Recruiting
Start date
February 20, 2023
Completion date
December 1, 2027
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, lung embolism, pneumonia, radiation exposure